Example of Hepatitis Monthly format
Recent searches

Example of Hepatitis Monthly format Example of Hepatitis Monthly format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Hepatitis Monthly format Example of Hepatitis Monthly format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.

Hepatitis Monthly — Template for authors

Categories Rank Trend in last 3 yrs
Infectious Diseases #209 of 288 down down by 99 ranks
Hepatology #47 of 62 down down by 16 ranks
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 226 Published Papers | 347 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 12/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Wiley

Quality:  
High
CiteRatio: 6.1
SJR: 1.329
SNIP: 1.058
open access Open Access
recommended Recommended

PLOS

Quality:  
High
CiteRatio: 7.1
SJR: 1.99
SNIP: 1.774
open access Open Access

American Chemical Society

Quality:  
High
CiteRatio: 6.0
SJR: 1.324
SNIP: 1.029
open access Open Access
recommended Recommended

Oxford University Press

Quality:  
High
CiteRatio: 9.1
SJR: 2.124
SNIP: 1.646

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

0.705

55% from 2018

Impact factor for Hepatitis Monthly from 2016 - 2019
Year Value
2019 0.705
2018 1.578
2017 1.81
2016 1.677
graph view Graph view
table view Table view

1.5

61% from 2019

CiteRatio for Hepatitis Monthly from 2016 - 2020
Year Value
2020 1.5
2019 3.8
2018 3.4
2017 3.6
2016 3.4
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 55% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has decreased by 61% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.264

40% from 2019

SJR for Hepatitis Monthly from 2016 - 2020
Year Value
2020 0.264
2019 0.441
2018 0.509
2017 0.785
2016 0.661
graph view Graph view
table view Table view

0.474

33% from 2019

SNIP for Hepatitis Monthly from 2016 - 2020
Year Value
2020 0.474
2019 0.709
2018 0.672
2017 0.902
2016 0.897
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 40% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 33% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Hepatitis Monthly

Guideline source: View

Potential, possible, or probable predatory scholarly open-access publishers.

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Kowsar Publishing Company

Hepatitis Monthly

Approved by publishing and review experts on SciSpace, this template is built as per for Hepatitis Monthly formatting guidelines as mentioned in Kowsar Publishing Company author instructions. The current version was created on 11 Jul 2020 and has been used by 145 authors to write and format their manuscripts to this journal.

i
Last updated on
11 Jul 2020
i
ISSN
1735-3408
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
Vancouver
i
Citation Type
Numbered
(25)
i
Bibliography Example
Blonder GE, Tinkham M, Klapwijk TM. Tran- sition from metallic to tunneling regimes in su- perconducting microconstrictions: Excess cur- rent, charge imbalance, and supercurrent con- version. Phys Rev B. 1982;25(7):4515–4532.

Top papers written in this journal

open accessOpen access Journal Article
Hepatitis B Virus Infection in Iran: A Systematic Review
31 Dec 2008 - Hepatitis Monthly

Abstract:

Results: Fourteen studies met the inclusion criteria. They were from 7 (out of 30) provinces in which about 40 percent of the country population live. These provinces (HBsAg positive prevalence) were Golestan (6.3%), Tehran (2.2%), East Azarbaijan (1.3%), Hamedan (2.3%), Isfahan (1.3%), Kermanshah (1.3%) and Hormozgan (2.4%).... Results: Fourteen studies met the inclusion criteria. They were from 7 (out of 30) provinces in which about 40 percent of the country population live. These provinces (HBsAg positive prevalence) were Golestan (6.3%), Tehran (2.2%), East Azarbaijan (1.3%), Hamedan (2.3%), Isfahan (1.3%), Kermanshah (1.3%) and Hormozgan (2.4%). The HBV infection prevalence in Iran is estimated to be 2.14 percent (95%CI: 1.92-2.35), in men and women 2.55 percent (95%CI: 2.252.85) and 2.03 percent (95%CI: 1.6-2.46 percent) respectively. Conclusions: About 1.5 million people in Iran are living with HBV infection (mild to moderate prevalence according to WHO classification) and it is assumed that 15% to 40% of them are at risk of developing cirrhosis and/or hepatocellular carcinoma (HCC) without intervention. The prevalence of HBV infection has been reported higher in more recent studies compared to the study in 2000-2001. read more read less

Topics:

Population (52%)52% related to the paper, HBsAg (50%)50% related to the paper
210 Citations
open accessOpen access Journal Article
The relationship between lipid profile and severity of liver damage in cirrhotic patients.
01 Dec 2010 - Hepatitis Monthly

Abstract:

Background and Aims: An impaired lipid metabolism is often observed in patients with chronic liver diseases To determine lipid profile in patients with cirrhosis and to asses if it relates to the severity of the cirrhosis Materials and Methods: In an analytical cross-sectional study, 50 patients with cirrhosis (case) and 50 a... Background and Aims: An impaired lipid metabolism is often observed in patients with chronic liver diseases To determine lipid profile in patients with cirrhosis and to asses if it relates to the severity of the cirrhosis Materials and Methods: In an analytical cross-sectional study, 50 patients with cirrhosis (case) and 50 age- and sexmatched healthy normolipidemic patients (comparison) were studied A questionnaire including personal characteristics, etiology of cirrhosis, pathologic criteria of CHILD and MELD and lipid profile (total, LDL, and HDL cholesterol and triglyceride) was completed for each patient Results: In patients with cirrhosis, there was a significant decrease in serum triglyceride, total, LDL and HDL cholesterol levels compared to the comparison group (mean of 82 vs 187, 138 vs 184, 80 vs 137, and 40 vs 44 mg/dL, respectively; all p<005) Comparison of lipid profile with pathologic progression of cirrhosis revealed that except for serum triglyceride level, serum lipid levels diminishe linearly with progression of liver damage Conclusions: Serum total, LDL and HDL cholesterol level in patients with cirrhosis is inversely correlate with severity of cirrhosis read more read less

Topics:

Lipid profile (59%)59% related to the paper, Cirrhosis (56%)56% related to the paper, Blood serum (55%)55% related to the paper, Cholesterol (52%)52% related to the paper, Blood lipids (52%)52% related to the paper
123 Citations
open accessOpen access Journal Article DOI: 10.5812/HEPATMON.9248
Non alcoholic fatty liver disease in southern Iran: a population based study.
23 May 2013 - Hepatitis Monthly

Abstract:

Background Population based studies on prevalence and risk factors of NAFLD in Iranian population are few. The prevalence of NAFLD and non alcoholic steatohepatitis (NASH) in Iranians varies from 2.9% to 7.1% in general population and 55.8% in patients with type 2 diabetes mellitus. Background Population based studies on prevalence and risk factors of NAFLD in Iranian population are few. The prevalence of NAFLD and non alcoholic steatohepatitis (NASH) in Iranians varies from 2.9% to 7.1% in general population and 55.8% in patients with type 2 diabetes mellitus. read more read less

Topics:

Population (59%)59% related to the paper, Steatohepatitis (55%)55% related to the paper, Fatty liver (53%)53% related to the paper, Type 2 Diabetes Mellitus (50%)50% related to the paper
View PDF
118 Citations
open accessOpen access Journal Article
Hepatitis C infection in the general population of Iran: a systematic review.
30 Sep 2009 - Hepatitis Monthly

Abstract:

books by two independent reviewers. We also searched the research projects of 29 out of 40 Iranian universities of medical sciences from their websites. We contacted the Center for Disease Control (CDC) of the Iranian Ministry of Health and the Iranian Blood Transfusion Organization (IBTO) for searching national reports from ... books by two independent reviewers. We also searched the research projects of 29 out of 40 Iranian universities of medical sciences from their websites. We contacted the Center for Disease Control (CDC) of the Iranian Ministry of Health and the Iranian Blood Transfusion Organization (IBTO) for searching national reports from the study time period. Medical students’ theses were also evaluated by two independent reviewers from the Iranian center for scientific documents and records (IranDoc). Finally, we consulted eight expert HCV researchers in Iran and searched their personal archives for additional citations. Forward and backward citations of searched items were also performed. Critical appraisal and selection of studies Two independent reviewers reviewed all citations thoroughly and checked for eligibility criteria to include the studies in the analysis. The inclusion criteria were all cross-sectional studies that specified temporal and geographic characteristics of the study; sufficiently declared objectives; and that used a valid 213 Seyed Moayed Alavian et al. Hepatitis Monthly, Summer 2009; 9(3): 211-223 sampling method that allowed for a generalization of the findings to the target population, valid measurement instruments for all study subjects, and appropriate analytic methods for the given sampling design and demographic characteristics. We revised the criteria developed by Sharifi et al. for this purpose (12). Data extraction After evaluating studies on these criteria, we extracted the findings of the included studies to Excel spreadsheets. The extracted data were year of the study, first author, province and district of the study, sample population, sampling method, sample size, HCV Antibody detection method, HCV Antibody kit name, mean age and standard error (SE) of subjects, percentage of male subjects, and HCV point prevalence in study subjects and/or in males/females and its SE. If there were other parameters reported other than SE, such as standard deviation, confidence interval, and/or P.value, the proper modifications were performed to calculate SE. Statistical analysis We analyzed the extracted data to estimate the point prevalence of HCV infection and its 95% confidence interval (CI) and used a Cochrane Q-test with a significance level of < 0.1 for checking the statistical heterogeneity of the results. We used a meta-analysis method with the “meta” command using fix/random model based on the results of the heterogeneity test. It seems that the meta-analysis method would not have been a suitable method to achieve the objectives of this systematic review because the weighting system of this method only considers sample size and not the size of the provincial population. We used a survey data analysis method to calculate the estimate of the nationwide prevalence rate considering the weight of each province as the ratio of the provincial population to the sample size(s), where the population of each province was retrieved from the Iranian national census at 2006 (7). In provinces with more than one prevalnce study (Tehran and Sistan-va-Baluchestan), the provincial prevalence was calculated by a meta-analysis of the studies, and the total sample size was determined by adding all study sample sizes. The analysis was performed with STATA 9.1 software (STATA Corp. LP). The results were shown in geographic maps using Arc View 3.2a software (ESRI Inc. NY). read more read less

Topics:

Population (57%)57% related to the paper, Systematic review (53%)53% related to the paper, Hepatitis C (53%)53% related to the paper, Prevalence (52%)52% related to the paper
113 Citations
open accessOpen access Journal Article DOI: 10.5812/HEPATMON.18672
Role of MicroRNAs in Hepatocellular Carcinoma.
Zixiang Zhu, Xiangle Zhang, Guoqing Wang1, Haixue Zheng
01 Aug 2014 - Hepatitis Monthly

Abstract:

Context: MicroRNAs (miRNAs) are small, noncoding RNAs that play an important role in posttranscriptional gene regulation and function as negative gene regulators. They are an abundant class of RNA, each of which can control hundreds of gene targets and regulate diverse biological processes such as hematopoiesis, organogenesis... Context: MicroRNAs (miRNAs) are small, noncoding RNAs that play an important role in posttranscriptional gene regulation and function as negative gene regulators. They are an abundant class of RNA, each of which can control hundreds of gene targets and regulate diverse biological processes such as hematopoiesis, organogenesis, apoptosis and cell proliferation. Aberrant miRNA expression contributes to tumorigenesis and cancer progression. Evidence Acquisition: In this study we provided a summarized review of the most important new data available on hepatocellular carcinoma (HCC)-associated miRNAs. The data were collected through searching the related keywords and were categorized and summarized in different sections. Results: Researchers have reported that miRNAs can repress the expression of important cancer-related genes and might be helpful in the diagnosis and treatment of cancer. During the past two decades, numerous studies have shown that miRNAs play an essential role in inhibiting HCC via several different pathways. Deregulated miRNAs may contribute to carcinogenesis, indicating that miRNAs can act as tumor suppressors and oncogenes. Conclusions: In this mini review, we highlight current findings and discuss recent work to determine the contribution of miRNA expression to the maintenance and growth of HCC, thereby providing a significant source of hope that miRNAs could serve as therapeutic targets. read more read less

Topics:

Regulation of gene expression (51%)51% related to the paper, microRNA (50%)50% related to the paper
View PDF
109 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Hepatitis Monthly.

It automatically formats your research paper to Kowsar Publishing Company formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Hepatitis Monthly format uses Vancouver citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Hepatitis Monthly in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Hepatitis Monthly guidelines and auto format it.

2. Do you follow the Hepatitis Monthly guidelines?

Yes, the template is compliant with the Hepatitis Monthly guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Hepatitis Monthly?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Hepatitis Monthly citation style.

4. Can I use the Hepatitis Monthly templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Hepatitis Monthly.

5. Can I use a manuscript in Hepatitis Monthly that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Hepatitis Monthly that you can download at the end.

6. How long does it usually take you to format my papers in Hepatitis Monthly?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Hepatitis Monthly.

7. Where can I find the template for the Hepatitis Monthly?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Hepatitis Monthly's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Hepatitis Monthly's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Hepatitis Monthly an online tool or is there a desktop version?

SciSpace's Hepatitis Monthly is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Hepatitis Monthly?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Hepatitis Monthly?”

11. What is the output that I would get after using Hepatitis Monthly?

After writing your paper autoformatting in Hepatitis Monthly, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Hepatitis Monthly's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Hepatitis Monthly?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Hepatitis Monthly. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Hepatitis Monthly?

The 5 most common citation types in order of usage for Hepatitis Monthly are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Hepatitis Monthly?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Hepatitis Monthly's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Hepatitis Monthly in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Hepatitis Monthly Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Hepatitis Monthly formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template